Canadian Press - OTTAWA (CP) - For the first time in Canadian drug regulatory history, experts who advise Health Canada queried drug company officials in public Thursday and heard the views of consumers as they prepared to recommend how or if controversial painkillers known as cox-2 inhibitors should be used in Canada.{br}{br}View the Entire Article{br}